アンチウイルスの世界市場動向・分析2018-2025

【英語タイトル】Global Antivirals Industry Research Report, Growth Trends and Competitive Analysis 2018-2025

QYResearchが出版した調査資料(QYR8D00532)・商品コード:QYR8D00532
・発行会社(調査会社):QYResearch
・発行日:2018年10月31日(※2024年版があります。お問い合わせください)
・ページ数:110
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、世界主要国
・産業分野:製薬・ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは、アンチウイルスの世界市場について調査・分析し、種類別には、ジェネリック、ブランドに、用途別には、アプリケーション1、HIV、肝炎、HSV、インフルエンザに区分してまとめました。調査対象企業は、Merck & Co、Johnson & Johnson、Teva Pharmaceutical Industries、GSK、Mylan、Gilead Sciences、F. Hoffmann-La Roche AG、Bristol-Myers-Squibb、AbbVie、Aurobindo Pharma、Cipla、Dr Reddy’s等です。

・レポートの概要
・グローバル成長トレンド
・アンチウイルスの世界市場規模
・アンチウイルスの地域別市場規模
・グローバル産業動向
・企業別市場シェア
・企業別アンチウイルスの価格動向
・アンチウイルスの種類別市場規模(ジェネリック、ブランド)
・アンチウイルスの用途別市場規模(アプリケーション1、HIV、肝炎、HSV、インフルエンザ)
・アンチウイルスの北米市場(アメリカ、カナダ、メキシコ)
・アンチウイルスのヨーロッパ市場(ドイツ、フランス、イギリス、イタリア、ロシア)
・アンチウイルスのアジア市場(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・アンチウイルスの中南米市場(ブラジル等)
・アンチウイルスの中東・アフリカ市場(GCC、エジプト、南アフリカ)
・主要企業情報(Merck & Co、Johnson & Johnson、Teva Pharmaceutical Industries、GSK、Mylan、Gilead Sciences、F. Hoffmann-La Roche AG、Bristol-Myers-Squibb、AbbVie、Aurobindo Pharma、Cipla、Dr Reddy’s)
 -企業概要、事業概要、販売・売上・市場シェア、XXX製品概要、企業動向
・バリューチェーン及び販売チャネル分析
・アンチウイルスの市場規模予測
・アンチウイルスの種類別市場予測2018-2025(ジェネリック、ブランド)
・アンチウイルスの用途別市場予測2018-2025(アプリケーション1、HIV、肝炎、HSV、インフルエンザ)
・アンチウイルスの北米市場予測2018-2025(アメリカ、カナダ、メキシコ)
・アンチウイルスのヨーロッパ市場予測2018-2025(ドイツ、フランス、イギリス、イタリア、ロシア)
・アンチウイルスのアジア市場予測2018-2025(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・アンチウイルスの中南米市場予測2018-2025(ブラジル等)
・アンチウイルスの中東・アフリカ市場予測2018-2025(GCC、エジプト、南アフリカ)
・調査結果及び結論
【レポートの概要】

Antiviral drugs are a class of medication used specifically for treating viral infections rather than bacterial ones. Most antivirals are used for specific viral infections, while a broad-spectrum antiviral is effective against a wide range of viruses. Unlike most antibiotics, antiviral drugs do not destroy their target pathogen; instead they inhibit their development.In 2018, the global Antivirals market size was 46000 million US$ and is forecast to 65400 million US in 2025, growing at a CAGR of 4.5% from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Antivirals.

This study researches the market size of Antivirals, presents the global Antivirals sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.
This report focuses on the key data information of Antivirals in key regions like North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, presents sales, revenue, market share, growth rate of Antivirals for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2013 to 2018.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.
Merck & Co
Johnson & Johnson
Teva Pharmaceutical Industries
GSK
Mylan
Gilead Sciences
F. Hoffmann-La Roche AG
Bristol-Myers-Squibb
AbbVie
Aurobindo Pharma
Cipla
Dr Reddy’s

Market Segment by Product Type
Generic
Branded

Market Segment by Application
Application 1
HIV
Hepatitis
HSV
Influenza

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global Antivirals status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Antivirals manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Antivirals are as follows:
History Year: 2013-2018
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Antivirals Market Size Growth Rate by Type
1.3.2 Generic
1.3.3 Branded
1.4 Market Segment by Application
1.4.1 Global Antivirals Market Share by Application (2018-2025)
1.4.2 Application 1
1.4.3 HIV
1.4.4 Hepatitis
1.4.5 HSV
1.4.6 Influenza
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Antivirals Market Size
2.1.1 Global Antivirals Revenue 2013-2025
2.1.2 Global Antivirals Sales 2013-2025
2.2 Antivirals Growth Rate by Regions
2.2.1 Global Antivirals Sales by Regions 2013-2018
2.2.2 Global Antivirals Revenue by Regions 2013-2018
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Antivirals Sales by Manufacturers
3.1.1 Antivirals Sales by Manufacturers 2013-2018
3.1.2 Antivirals Sales Market Share by Manufacturers 2013-2018
3.2 Revenue by Manufacturers
3.2.1 Antivirals Revenue by Manufacturers (2013-2018)
3.2.2 Antivirals Revenue Share by Manufacturers (2013-2018)
3.2.3 Global Antivirals Market Concentration Ratio (CR5 and HHI)
3.3 Antivirals Price by Manufacturers
3.4 Key Manufacturers Antivirals Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Antivirals Market
3.6 Key Manufacturers Antivirals Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Generic Sales and Revenue (2013-2018)
4.1.2 Branded Sales and Revenue (2013-2018)
4.2 Global Antivirals Sales Market Share by Type
4.3 Global Antivirals Revenue Market Share by Type
4.4 Antivirals Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Antivirals Sales by Application

6 North America
6.1 North America Antivirals Breakdown Data by Company
6.2 North America Antivirals Breakdown Data by Type
6.3 North America Antivirals Breakdown Data by Application
6.4 North America Antivirals Breakdown Data by Countries
6.4.1 North America Antivirals Sales by Countries
6.4.2 North America Antivirals Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico

7 Europe
7.1 Europe Antivirals Breakdown Data by Company
7.2 Europe Antivirals Breakdown Data by Type
7.3 Europe Antivirals Breakdown Data by Application
7.4 Europe Antivirals Breakdown Data by Countries
7.4.1 Europe Antivirals Sales by Countries
7.4.2 Europe Antivirals Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Antivirals Breakdown Data by Company
8.2 Asia Pacific Antivirals Breakdown Data by Type
8.3 Asia Pacific Antivirals Breakdown Data by Application
8.4 Asia Pacific Antivirals Breakdown Data by Countries
8.4.1 Asia Pacific Antivirals Sales by Countries
8.4.2 Asia Pacific Antivirals Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Thailand
8.4.12 Vietnam

9 Central & South America
9.1 Central & South America Antivirals Breakdown Data by Company
9.2 Central & South America Antivirals Breakdown Data by Type
9.3 Central & South America Antivirals Breakdown Data by Application
9.4 Central & South America Antivirals Breakdown Data by Countries
9.4.1 Central & South America Antivirals Sales by Countries
9.4.2 Central & South America Antivirals Revenue by Countries
9.4.3 Brazil

10 Middle East and Africa
10.1 Middle East and Africa Antivirals Breakdown Data by Type
10.2 Middle East and Africa Antivirals Breakdown Data by Application
10.3 Middle East and Africa Antivirals Breakdown Data by Countries
10.3.1 Middle East and Africa Antivirals Sales by Countries
10.3.2 Middle East and Africa Antivirals Revenue by Countries
10.3.3 GCC Countries
10.3.4 Egypt
10.3.5 South Africa

11 Company Profiles
11.1 Merck & Co
11.1.1 Merck & Co Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Antivirals
11.1.4 Antivirals Product Introduction
11.1.5 Merck & Co Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Antivirals
11.2.4 Antivirals Product Introduction
11.2.5 Johnson & Johnson Recent Development
11.3 Teva Pharmaceutical Industries
11.3.1 Teva Pharmaceutical Industries Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Antivirals
11.3.4 Antivirals Product Introduction
11.3.5 Teva Pharmaceutical Industries Recent Development
11.4 GSK
11.4.1 GSK Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Antivirals
11.4.4 Antivirals Product Introduction
11.4.5 GSK Recent Development
11.5 Mylan
11.5.1 Mylan Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Antivirals
11.5.4 Antivirals Product Introduction
11.5.5 Mylan Recent Development
11.6 Gilead Sciences
11.6.1 Gilead Sciences Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Antivirals
11.6.4 Antivirals Product Introduction
11.6.5 Gilead Sciences Recent Development
11.7 F. Hoffmann-La Roche AG
11.7.1 F. Hoffmann-La Roche AG Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of Antivirals
11.7.4 Antivirals Product Introduction
11.7.5 F. Hoffmann-La Roche AG Recent Development
11.8 Bristol-Myers-Squibb
11.8.1 Bristol-Myers-Squibb Company Details
11.8.2 Company Description and Business Overview
11.8.3 Sales, Revenue and Market Share of Antivirals
11.8.4 Antivirals Product Introduction
11.8.5 Bristol-Myers-Squibb Recent Development
11.9 AbbVie
11.9.1 AbbVie Company Details
11.9.2 Company Description and Business Overview
11.9.3 Sales, Revenue and Market Share of Antivirals
11.9.4 Antivirals Product Introduction
11.9.5 AbbVie Recent Development
11.10 Aurobindo Pharma
11.10.1 Aurobindo Pharma Company Details
11.10.2 Company Description and Business Overview
11.10.3 Sales, Revenue and Market Share of Antivirals
11.10.4 Antivirals Product Introduction
11.10.5 Aurobindo Pharma Recent Development
11.11 Cipla
11.12 Dr Reddy’s

12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Antivirals Sales Channels
12.2.2 Antivirals Distributors
12.3 Antivirals Customers

13 Market Forecast
13.1 Global Antivirals Sales and Revenue Forecast 2018-2025
13.2 Global Antivirals Sales Forecast by Type
13.3 Global Antivirals Sales Forecast by Application
13.4 Antivirals Forecast by Regions
13.4.1 Global Antivirals Sales Forecast by Regions 2018-2025
13.4.2 Global Antivirals Revenue Forecast by Regions 2018-2025
13.5 North America Market Forecast
13.5.1 North America Antivirals Forecast by Countries 2018-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Antivirals Forecast by Countries 2018-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Antivirals Sales Forecast by Countries 2018-2025
13.7.2 China
13.7.3 Japan
13.7.4 Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Antivirals Sales Forecast by Countries 2018-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Antivirals Sales Forecast by Countries 2018-2025
13.9.2 GCC Countries
13.9.3 Egypt
13.9.4 South Africa

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Tables and Figures

Figure Antivirals Product Picture
Table Antivirals Key Market Segments
Table Major Manufacturers Antivirals Covered in This Report
Table Global Antivirals Market Size Growth Rate by Type 2018-2025 (K Units) & (Million US$)
Figure Global Antivirals Sales Market Shar by Type 2013-2025
Figure Generic Figures
Table Major Manufacturers of Generic
Figure Branded Figures
Table Major Manufacturers of Branded
Table Global Antivirals Market Share by Application 2018-2025 (K Units)
Figure Application 1 Use Case
Figure HIV Use Case
Figure Hepatitis Use Case
Figure HSV Use Case
Figure Influenza Use Case
Figure Antivirals Report Years Considered
Figure Global Antivirals Market Size 2013-2025 (Million US$)
Figure Global Antivirals Sales 2013-2018 (K Units)
Table Global Antivirals Market Size by Regions 2013-2018 (K Units) & (Million US$)
Table Global Antivirals Sales by Regions 2013-2018 (K Units)
Table Global Antivirals Sales Market Share by Regions 2013-2018
Figure Global Antivirals Sales Market Share by Regions 2013-2018
Figure Global Antivirals Sales Market Share by Regions in 2018
Table Global Antivirals Revenue by Regions 2013-2018 (Million US$)
Table Global Antivirals Revenue Market Share by Regions 2013-2018
Figure Global Antivirals Revenue Market Share by Regions 2013-2018
Figure Global Antivirals Revenue Market Share by Regions in 2018
Table Market Top Trends
Table Global Antivirals Sales by Manufacturers (2013-2018) (K Units)
Table Global Antivirals Sales Share by Manufacturers (2013-2018)
Figure Global Antivirals Sales Share by Manufacturers in 2018
Table Antivirals Revenue by Manufacturers (2013-2018) (Million USD)
Table Antivirals Revenue Share by Manufacturers (2013-2018)
Figure Antivirals Value Share by Manufacturers in 2018
Table Global Antivirals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Antivirals Price (2013-2018) (USD/Unit)
Table Key Manufacturers Antivirals Plants/Factories Distribution
Table Key Manufacturers Antivirals Area Served
Table Date of Key Manufacturers Enter into Antivirals Market
Table Key Manufacturers Antivirals Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Generic Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global Branded Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global Antivirals Sales by Type (2013-2018) (K Units)
Table Global Antivirals Sales Share by Type (2013-2018)
Figure Global Antivirals Sales Market Share by Type (2013-2018)
Figure Global Antivirals Sales Market Share by Type in 2017
Table Global Antivirals Revenue by Type (2013-2018) (Million US$)
Table Global Antivirals Revenue Share by Type (2013-2018)
Figure Global Antivirals Revenue Market Share by Type (2013-2018)
Figure Global Antivirals Revenue Market Share by Type in 2017
Table Antivirals Price by Type 2013-2018 (USD/Unit)
Table Global Antivirals Sales by Application (2013-2018) (K Units)
Table Global Antivirals Sales Share by Application (2013-2018)
Figure Global Sales Antivirals Market Share by Application (2013-2018)
Figure Global Sales Antivirals Market Share by Application in 2017
Figure North America Antivirals Sales Growth Rate 2013-2018 (K Units)
Figure North America Antivirals Revenue Growth Rate 2013-2018 (Million US$)
Table North America Antivirals Sales by Company (2013-2018) (K Units)
Table North America Antivirals Sales Market Share by Company (2013-2018)
Figure North America Antivirals Sales Market Share by Company in 2018
Table North America Antivirals Sales by Type (2013-2018) (K Units)
Table North America Antivirals Sales Market Share by Type (2013-2018)
Figure North America Antivirals Market Share by Type in 2018
Table North America Antivirals Sales by Application (2013-2018) (K Units)
Table North America Antivirals Sales Market Share by Application (2013-2018)
Figure North America Antivirals Market Share by Application in 2018
Table North America Antivirals Sales by Countries (2013-2018) (K Units)
Table North America Antivirals Sales Market Share by Countries (2013-2018)
Figure 2017 North America Antivirals Sales Market Share by Countries
Table North America Antivirals Revenue by Countries (2013-2018) (Million US$)
Table North America Antivirals Revenue Market Share by Countries (2013-2018)
Figure 2017 North America Antivirals Revenue Market Share by Countries
Figure United States Antivirals Sales Growth Rate (2013-2018) (K Units)
Figure Canada Antivirals Sales Growth Rate (2013-2018) (K Units)
Figure Mexico Antivirals Sales Growth Rate (2013-2018) (K Units)
Figure Europe Antivirals Sales Growth Rate 2013-2018 (K Units)
Figure Europe Antivirals Revenue Growth Rate 2013-2018 (Million US$)
Table Europe Antivirals Sales by Company (2013-2018) (K Units)
Table Europe Antivirals Sales Market Share by Company (2013-2018)
Figure Europe Antivirals Sales Market Share by Company in 2018
Table Europe Antivirals Sales by Type (2013-2018) (K Units)
Table Europe Antivirals Sales Market Share by Type (2013-2018)
Figure 2017 Europe Antivirals Market Share by Type
Table Europe Antivirals Sales by Application (2013-2018) (K Units)
Table Europe Antivirals Sales Market Share by Application (2013-2018)
Figure 2017 Europe Antivirals Market Share by Application
Table Europe Antivirals Sales by Countries (2013-2018) (K Units)
Table Europe Antivirals Sales Market Share by Countries (2013-2018)
Figure 2017 Europe Antivirals Sales Market Share by Countries
Table Europe Antivirals Revenue by Countries (2013-2018) (Million US$)
Table Europe Antivirals Revenue Market Share by Countries (2013-2018)
Figure Europe Antivirals Revenue Market Share by Countries in 2018
Figure Germany Antivirals Sales Growth Rate (2013-2018) (K Units)
Figure France Antivirals Sales Growth Rate (2013-2018) (K Units)
Figure UK Antivirals Sales Growth Rate (2013-2018) (K Units)
Figure Italy Antivirals Sales Growth Rate (2013-2018) (K Units)
Figure Russia Antivirals Sales Growth Rate (2013-2018) (K Units)
Figure Asia Pacific Antivirals Sales Growth Rate 2013-2018 (K Units)
Figure Asia Pacific Antivirals Revenue Growth Rate 2013-2018 (Million US$)
Table Asia Pacific Antivirals Sales by Company (2013-2018) (K Units)
Table Asia Pacific Antivirals Sales Market Share by Company (2013-2018)
Figure Asia Pacific Antivirals Sales Market Share by Company in 2018
Table Asia Pacific Antivirals Sales by Type (2013-2018) (K Units)
Table Asia Pacific Antivirals Sales Market Share by Type (2013-2018)
Figure Asia Pacific Antivirals Market Share by Type in 2018
Table Asia Pacific Antivirals Sales by Application (2013-2018) (K Units)
Table Asia Pacific Antivirals Sales Market Share by Application (2013-2018)
Figure Asia Pacific Antivirals Market Share by Application in 2018
Table Asia Pacific Antivirals Sales by Countries (2013-2018) (K Units)
Table Asia Pacific Antivirals Sales Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Antivirals Sales Market Share by Countries
Table Asia Pacific Antivirals Revenue by Countries (2013-2018) (Million US$)
Table Asia Pacific Antivirals Revenue Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Antivirals Revenue Market Share by Countries
Figure China Antivirals Sales Growth Rate (2013-2018) (K Units)
Figure China Antivirals Revenue Growth Rate (2013-2018) (Million US$)
Figure Japan Antivirals Sales Growth Rate (2013-2018) (K Units)
Figure Japan Antivirals Revenue Growth Rate (2013-2018) (Million US$)
Figure Korea Antivirals Sales Growth Rate (2013-2018) (K Units)
Figure Korea Antivirals Revenue Growth Rate (2013-2018) (Million US$)
Figure India Antivirals Sales Growth Rate (2013-2018) (K Units)
Figure India Antivirals Revenue Growth Rate (2013-2018) (Million US$)
Figure Australia Antivirals Sales Growth Rate (2013-2018) (K Units)
Figure Australia Antivirals Revenue Growth Rate (2013-2018) (Million US$)
Figure Indonesia Antivirals Sales Growth Rate (2013-2018) (K Units)
Figure Indonesia Antivirals Revenue Growth Rate (2013-2018) (Million US$)
Figure Malaysia Antivirals Sales Growth Rate (2013-2018) (K Units)
Figure Malaysia Antivirals Revenue Growth Rate (2013-2018) (Million US$)
Figure Philippines Antivirals Sales Growth Rate (2013-2018) (K Units)
Figure Philippines Antivirals Revenue Growth Rate (2013-2018) (Million US$)
Figure Thailand Antivirals Sales Growth Rate (2013-2018) (K Units)
Figure Thailand Antivirals Revenue Growth Rate (2013-2018) (Million US$)
Figure Vietnam Antivirals Sales Growth Rate (2013-2018) (K Units)
Figure Vietnam Antivirals Revenue Growth Rate (2013-2018) (Million US$)
Figure Central & South America Antivirals Sales Growth Rate 2013-2018 (K Units)
Figure Central & South America Antivirals Revenue Growth Rate 2013-2018 (Million US$)
Table Central & South America Antivirals Sales by Company (2013-2018) (K Units)
Table Central & South America Antivirals Sales Market Share by Company (2013-2018)
Figure Central & South America Antivirals Sales Market Share by Company in 2018
Table Central & South America Antivirals Sales by Type (2013-2018) (K Units)
Table Central & South America Antivirals Sales Market Share by Type (2013-2018)
Figure Central & South America Antivirals Market Share by Type in 2018
Table Central & South America Antivirals Sales by Application (2013-2018) (K Units)
Table Central & South America Antivirals Sales Market Share by Application (2013-2018)
Figure Central & South America Antivirals Market Share by Application in 2018
Table Central & South America Antivirals Sales by Countries (2013-2018) (K Units)
Table Central & South America Antivirals Sales Market Share by Countries (2013-2018)
Figure Central & South America Antivirals Sales Market Share by Countries in 2018
Table Central & South America Antivirals Revenue by Countries (2013-2018) (Million US$)
Table Central & South America Antivirals Revenue Market Share by Countries (2013-2018)
Figure Central & South America Antivirals Revenue Market Share by Countries in 2018
Figure Brazil Antivirals Sales Growth Rate (2013-2018) (K Units)
Figure Brazil Antivirals Revenue Growth Rate (2013-2018) (K Units)
Figure Middle East and Africa Antivirals Sales Growth Rate 2013-2018 (K Units)
Figure Middle East and Africa Antivirals Revenue Growth Rate 2013-2018 (Million US$)
Table Middle East and Africa Antivirals Sales by Type (2013-2018) (K Units)
Table Middle East and Africa Antivirals Sales Market Share by Type (2013-2018)
Figure 2017 Middle East and Africa Antivirals Market Share by Type
Table Middle East and Africa Antivirals Sales by Application (2013-2018) (K Units)
Table Middle East and Africa Antivirals Sales Market Share by Application (2013-2018)
Figure 2017 Middle East and Africa Antivirals Market Share by Application
Table Middle East and Africa Antivirals Sales by Countries (2013-2018) (K Units)
Table Middle East and Africa Antivirals Sales Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Antivirals Sales Market Share by Countries
Table Middle East and Africa Antivirals Revenue by Countries (2013-2018) (Million US$)
Table Middle East and Africa Antivirals Revenue Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Antivirals Revenue Market Share by Countries
Figure GCC Countries Antivirals Sales Growth Rate (2013-2018) (K Units)
Figure GCC Countries Antivirals Revenue Growth Rate (2013-2018) (K Units)
Figure Egypt Antivirals Sales Growth Rate (2013-2018) (K Units)
Figure Egypt Antivirals Revenue Growth Rate (2013-2018) (K Units)
Figure South Africa Antivirals Sales Growth Rate (2013-2018) (K Units)
Figure South Africa Antivirals Revenue Growth Rate (2013-2018) (K Units)
Table Merck & Co Company Details
Table Merck & Co Description and Business Overview
Table Merck & Co Antivirals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Merck & Co Antivirals Sales Growth Rate (2013-2018)
Table Merck & Co Antivirals Sales Market Share in Global Market
Table Merck & Co Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Description and Business Overview
Table Johnson & Johnson Antivirals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Johnson & Johnson Antivirals Sales Growth Rate (2013-2018)
Table Johnson & Johnson Antivirals Sales Market Share in Global Market
Table Johnson & Johnson Recent Development
Table Teva Pharmaceutical Industries Company Details
Table Teva Pharmaceutical Industries Description and Business Overview
Table Teva Pharmaceutical Industries Antivirals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Teva Pharmaceutical Industries Antivirals Sales Growth Rate (2013-2018)
Table Teva Pharmaceutical Industries Antivirals Sales Market Share in Global Market
Table Teva Pharmaceutical Industries Recent Development
Table GSK Company Details
Table GSK Description and Business Overview
Table GSK Antivirals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table GSK Antivirals Sales Growth Rate (2013-2018)
Table GSK Antivirals Sales Market Share in Global Market
Table GSK Recent Development
Table Mylan Company Details
Table Mylan Description and Business Overview
Table Mylan Antivirals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Mylan Antivirals Sales Growth Rate (2013-2018)
Table Mylan Antivirals Sales Market Share in Global Market
Table Mylan Recent Development
Table Gilead Sciences Company Details
Table Gilead Sciences Description and Business Overview
Table Gilead Sciences Antivirals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Gilead Sciences Antivirals Sales Growth Rate (2013-2018)
Table Gilead Sciences Antivirals Sales Market Share in Global Market
Table Gilead Sciences Recent Development
Table F. Hoffmann-La Roche AG Company Details
Table F. Hoffmann-La Roche AG Description and Business Overview
Table F. Hoffmann-La Roche AG Antivirals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table F. Hoffmann-La Roche AG Antivirals Sales Growth Rate (2013-2018)
Table F. Hoffmann-La Roche AG Antivirals Sales Market Share in Global Market
Table F. Hoffmann-La Roche AG Recent Development
Table Bristol-Myers-Squibb Company Details
Table Bristol-Myers-Squibb Description and Business Overview
Table Bristol-Myers-Squibb Antivirals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Bristol-Myers-Squibb Antivirals Sales Growth Rate (2013-2018)
Table Bristol-Myers-Squibb Antivirals Sales Market Share in Global Market
Table Bristol-Myers-Squibb Recent Development
Table AbbVie Company Details
Table AbbVie Description and Business Overview
Table AbbVie Antivirals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table AbbVie Antivirals Sales Growth Rate (2013-2018)
Table AbbVie Antivirals Sales Market Share in Global Market
Table AbbVie Recent Development
Table Aurobindo Pharma Company Details
Table Aurobindo Pharma Description and Business Overview
Table Aurobindo Pharma Antivirals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Aurobindo Pharma Antivirals Sales Growth Rate (2013-2018)
Table Aurobindo Pharma Antivirals Sales Market Share in Global Market
Table Aurobindo Pharma Recent Development
Table Cipla Company Details
Table Dr Reddy’s Company Details
Figure Antivirals Value Chain
Table Antivirals Distributors List
Table Antivirals Customers List
Table Global Antivirals Sales Forecast 2018-2025 (K Units) & (Million US$)
Figure Global Antivirals Sales Forecast 2018-2025 (K Units)
Figure Global Antivirals Revenue Forecast 2018-2025 (Million US$)
Table Global Antivirals Sales Forecast by Type 2018-2025 (K Units)
Figure Global Antivirals Sales Forecast by Type 2018-2025 (K Units)
Figure Global Antivirals Sales Market Share Forecast by Type 2018-2025
Table Global Antivirals Sales Forecast by Application 2018-2025 (K Units)
Figure Global Antivirals Sales Forecast by Application 2018-2025 (K Units)
Figure Global Antivirals Sales Market Share Forecast by Application 2018-2025
Table Global Antivirals Sales Forecast by Regions 2018-2025 (K Units)
Figure Global Antivirals Sales Forecast by Regions 2018-2025 (K Units)
Figure Global Antivirals Sales Market Share Forecast by Regions 2018-2025
Table Global Antivirals Revenue Forecast by Regions 2018-2025 (Million US$)
Figure Global Antivirals Revenue Forecast by Regions 2018-2025 (Million US$)
Figure Global Antivirals Revenue Market Share Forecast by Regions 2018-2025
Table North America Antivirals Sales Forecast by Countries 2018-2025 (K Units)
Table North America Antivirals Sales Market Share Forecast by Countries 2018-2025
Table North America Antivirals Revenue Forecast by Countries 2018-2025 (Million US$)
Table North America Antivirals Revenue Market Share Forecast by Countries 2018-2025
Figure United States Antivirals Sales Forecast 2018-2025 (K Units)
Figure Canada Antivirals Sales Forecast 2018-2025 (K Units)
Figure MexicoAntivirals Sales Forecast 2018-2025 (K Units)
Table Europe Antivirals Sales Forecast by Countries 2018-2025 (K Units)
Table Europe Antivirals Sales Market Share Forecast by Countries 2018-2025
Table Europe Antivirals Revenue Forecast by Countries 2018-2025 (Million US$)
Table Europe Antivirals Revenue Market Share Forecast by Countries 2018-2025
Figure Germany Antivirals Sales Forecast 2018-2025 (K Units)
Figure France Antivirals Sales Forecast 2018-2025 (K Units)
Figure UK Antivirals Sales Forecast 2018-2025 (K Units)
Figure Italy Antivirals Sales Forecast 2018-2025 (K Units)
Figure Russia Antivirals Sales Forecast 2018-2025 (K Units)
Table Asia Pacific Antivirals Sales Forecast by Countries 2018-2025 (K Units)
Table Asia Pacific Antivirals Sales Market Share Forecast by Countries 2018-2025
Table Asia Pacific Antivirals Revenue Forecast by Countries 2018-2025 (Million US$)
Table Asia Pacific Antivirals Revenue Market Share Forecast by Countries 2018-2025
Figure China Antivirals Sales Forecast 2018-2025 (K Units)
Figure Japan Antivirals Sales Forecast 2018-2025 (K Units)
Figure Korea Antivirals Sales Forecast 2018-2025 (K Units)
Figure India Antivirals Sales Forecast 2018-2025 (K Units)
Figure Australia Antivirals Sales Forecast 2018-2025 (K Units)
Figure Indonesia Antivirals Sales Forecast 2018-2025 (K Units)
Figure Thailand Antivirals Sales Forecast 2018-2025 (K Units)
Figure Malaysia Antivirals Sales Forecast 2018-2025 (K Units)
Figure Philippines Antivirals Sales Forecast 2018-2025 (K Units)
Figure Vietnam Antivirals Sales Forecast 2018-2025 (K Units)
Table Central & South America Antivirals Sales Forecast by Countries 2018-2025 (K Units)
Table Central & South America Antivirals Sales Market Share Forecast by Countries 2018-2025
Table Central & South America Antivirals Revenue Forecast by Countries 2018-2025 (Million US$)
Table Central & South America Antivirals Revenue Market Share Forecast by Countries 2018-2025
Figure Brazil Antivirals Sales Forecast 2018-2025 (K Units)
Table Middle East and Africa Antivirals Sales Forecast by Regions 2018-2025 (K Units)
Table Middle East and Africa Antivirals Sales Market Share Forecast by Regions 2018-2025
Table Middle East and Africa Antivirals Revenue Forecast by Regions 2018-2025 (Million US$)
Table Middle East and Africa Antivirals Revenue Market Share Forecast by Regions 2018-2025
Figure GCC Countries Antivirals Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Antivirals Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Antivirals Sales Growth Rate (2016-2025) (K Units)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Merck & Co、Johnson & Johnson、Teva Pharmaceutical Industries、GSK、Mylan、Gilead Sciences、F. Hoffmann-La Roche AG、Bristol-Myers-Squibb、AbbVie、Aurobindo Pharma、Cipla、Dr Reddy’s

★調査レポート[アンチウイルスの世界市場動向・分析2018-2025] (コード:QYR8D00532)販売に関する免責事項を必ずご確認ください。
★調査レポート[アンチウイルスの世界市場動向・分析2018-2025]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆